| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥88.2B | ¥76.2B | +15.7% |
| Operating Income | ¥6.4B | ¥4.8B | +33.0% |
| Ordinary Income | ¥6.6B | ¥4.8B | +37.8% |
| Net Income | ¥4.6B | ¥3.3B | +40.1% |
| ROE | 22.8% | 20.1% | - |
FY2025 Q3 results: Revenue 88.2B yen (YoY +15.7%), Operating Income 6.4B yen (YoY +33.0%), Ordinary Income 6.6B yen (YoY +37.8%), Net Income 4.6B yen (YoY +40.1%). The company demonstrates strong top-line growth with accelerating profit expansion, marking a continuation of the positive earnings trajectory. All three reporting segments - Nursing, Care, and Temporary Staffing - contributed to revenue growth, with the Nursing segment representing the largest share. Operating margin improved to 7.2%, benefiting from operating leverage as revenue growth outpaced SG&A expense increases.
Revenue growth of 15.7% was driven by expansion across all business segments. The Nursing segment generated 48.7B yen (+15.8% YoY based on segment note comparison), representing the core business with the largest revenue contribution. The Care segment achieved 22.2B yen (+15.7% YoY), while the Temporary Staffing segment reached 14.5B yen (+20.2% YoY), showing the fastest growth rate among reporting segments. The segment notes indicate that all three main reporting segments plus the Other segment (primarily mobile business) increased sales year-over-year, demonstrating broad-based demand strength.
On the profit side, gross profit margin stood at 16.8%, generating 14.8B yen in gross profit. SG&A expenses were 8.4B yen, representing 9.5% of revenue, resulting in operating income of 6.4B yen. The operating margin of 7.2% reflects improvement from prior year levels, indicating positive operating leverage as revenue scaled faster than fixed cost absorption. The 33.0% increase in operating income significantly outpaced revenue growth, confirming effective cost management.
Ordinary income of 6.6B yen exceeded operating income by approximately 0.2B yen, with non-operating income of 0.5B yen partially offset by non-operating expenses of 0.3B yen. Interest expense of 0.2B yen remained modest relative to operating profit. Net income reached 4.6B yen after profit before tax of 6.6B yen, implying an effective tax rate of approximately 30.4%, which is within the standard corporate tax range. No significant extraordinary items were noted that would distort earnings quality.
This represents a revenue up, profit up pattern, with profit growth significantly outpacing revenue growth, indicating improving operational efficiency and scalability of the business model.
The Nursing segment is the core business, generating 48.7B yen in revenue (55.3% of total consolidated revenue) with operating income of 9.4B yen at a 19.3% margin. This segment demonstrates the highest profitability among reporting segments and serves as the primary earnings driver. Revenue increased 15.8% YoY with operating profit rising from 8.3B yen to 9.4B yen (+13.3% YoY based on segment note comparison), showing solid but slightly decelerating profit growth relative to revenue.
The Care segment contributed 22.2B yen in revenue (25.2% of total) with operating income of 1.0B yen at a 4.4% margin. This segment operates at significantly lower profitability compared to Nursing, with margin approximately one-quarter of the Nursing segment. Revenue grew 15.7% YoY while operating profit increased from 0.86B yen to 1.0B yen (+16.3% YoY), indicating stable but low-margin operations.
The Temporary Staffing segment generated 14.5B yen in revenue (16.5% of total) with operating income of 1.9B yen at a 12.8% margin. This segment showed the strongest revenue growth at 20.2% YoY, with operating profit expanding from 1.26B yen to 1.9B yen (+50.8% YoY), demonstrating strong operating leverage and suggesting favorable market conditions or improved placement efficiency.
Material margin differences exist across segments, with Nursing commanding premium profitability at 19.3%, Temporary Staffing at mid-level 12.8%, and Care operating at compressed 4.4% margins. Corporate headquarters expenses of approximately 6.2B yen are allocated as adjustments across segments. The diversified segment portfolio provides some revenue stability, though the company remains substantially dependent on the Nursing segment for profitability.
[Profitability] ROE 22.8% represents strong return on equity, substantially exceeding the prior year level and reflecting efficient capital deployment. Operating margin 7.2% improved from the prior year driven by operating leverage, though gross margin at 16.8% remains constrained relative to industry norms. Net profit margin 5.2% aligns with the operating structure, with effective tax rate approximately 30.4% and minimal interest burden. Basic EPS 61.20 yen increased 27.2% YoY, outpacing net income growth due to stable share count. [Cash Quality] Cash and deposits 19.6B yen represent substantial liquidity reserves, providing 5.33x coverage of short-term liabilities and demonstrating robust short-term financial flexibility. [Investment Efficiency] Asset turnover 1.698 indicates highly efficient asset utilization, substantially exceeding typical industry levels and contributing significantly to the elevated ROE through DuPont analysis. [Financial Health] Equity ratio 38.7% reflects moderate financial leverage, with total equity 20.1B yen against total assets 51.9B yen. Current ratio 153.9% indicates healthy working capital position. Long-term loans 6.4B yen decreased 29.0% from prior year 9.0B yen, demonstrating proactive debt reduction. Interest-bearing debt totaling approximately 10.1B yen results in debt-to-equity ratio 0.50x, maintaining conservative capital structure.
Cash and deposits increased 0.8B yen from prior year to reach 19.6B yen, maintaining strong liquidity despite business expansion. Total assets grew modestly from 50.6B yen to 51.9B yen, with the increase primarily reflected in retained earnings accumulation of 3.8B yen (36.0% increase from 10.6B yen to 14.5B yen), indicating profit generation exceeded dividend distributions and funded internal growth. Long-term borrowings decreased 2.6B yen (29.0% reduction), suggesting active debt repayment from operating cash generation. Working capital position remained healthy with current assets 33.6B yen covering current liabilities 21.9B yen, implying approximately 11.7B yen in working capital buffer. The combination of stable cash position, growing equity base, and declining debt levels indicates positive cash generation characteristics. Cash coverage of short-term obligations at 5.33x provides substantial liquidity cushion against operational volatility. The balance sheet structure suggests operating activities generate sufficient cash to fund working capital needs, service debt obligations, and support gradual deleveraging while maintaining ample liquidity reserves.
Operating income of 6.4B yen compared to ordinary income of 6.6B yen shows net non-operating contribution of approximately 0.2B yen, representing minimal impact on core operating results. Non-operating income totaled 0.5B yen while non-operating expenses were 0.3B yen, with interest expense of 0.2B yen as the primary cost component. The non-operating income breakdown shows approximately 0.2B yen in other non-operating income with negligible interest and dividend income, suggesting non-core gains from incidental sources. Non-operating items represent approximately 0.2% of revenue, indicating that earnings are overwhelmingly driven by core business operations rather than financial engineering or non-recurring gains. The close alignment between operating income and ordinary income confirms earnings quality is not distorted by non-operating factors. Interest burden coefficient of 1.032 demonstrates minimal financial cost drag on profitability. While quarterly cash flow statement detail is not available, the balance sheet evidence of cash accumulation alongside profit growth and the substantial cash-to-short-term-debt coverage ratio of 5.33x suggest operating cash generation supports reported earnings. The absence of material extraordinary items or restructuring charges, combined with profit growth across multiple segments, indicates sustainable earnings momentum backed by operational improvements rather than accounting treatments or one-time gains.
Full-year guidance targets revenue of 117.4B yen, operating income of 6.7B yen, and ordinary income of 6.8B yen. Against these targets, Q3 cumulative progress rates are: Revenue 75.1%, Operating Income 95.2%, and Ordinary Income 97.1%. The operating and ordinary income progress rates significantly exceed the standard 75% benchmark for Q3, indicating the company is tracking well ahead of plan. This suggests either conservative initial guidance or stronger-than-anticipated operational performance in the first nine months. The substantial over-achievement in profit metrics (95.2% and 97.1%) relative to revenue progress (75.1%) demonstrates margin expansion exceeding original assumptions. Full-year EPS forecast of 66.26 yen implies modest additional earnings contribution in Q4, with cumulative Q3 EPS of 61.20 yen already representing 92.4% of the annual target. Given the current run rate and the typical seasonal patterns, the company appears positioned to meet or potentially exceed full-year guidance. The absence of guidance revision despite strong progress suggests management confidence in sustainable performance without pulling forward future results.
Annual dividend forecast is 10.00 yen per share. Based on forecasted EPS of 66.26 yen, the payout ratio is approximately 15.1%, indicating a conservative dividend policy with substantial earnings retention. Compared to net income of 4.6B yen for Q3 cumulative and average shares outstanding of 7,479K, the implied annual dividend payment would be approximately 75 million yen, representing a conservative 16.4% payout relative to Q3 cumulative net income annualized. The low payout ratio provides significant dividend sustainability cushion and leaves ample cash for reinvestment or debt reduction. No share buyback activity was disclosed in the available data. The total shareholder return ratio, consisting solely of dividends at this conservative payout level, remains below 20%, suggesting the company prioritizes internal capital deployment for growth and financial strengthening over immediate cash returns to shareholders. The combination of strong ROE at 22.8%, low payout ratio, and substantial cash reserves of 19.6B yen indicates financial capacity exists for either dividend increases or capital returns, though current policy appears focused on balance sheet optimization as evidenced by the 29.0% reduction in long-term borrowings.
Gross margin compression risk: Gross profit margin of 16.8% is substantially below typical service industry benchmarks, indicating limited pricing power or high cost of service delivery. Further pressure on labor costs or competitive pricing could erode already-thin gross margins, directly impacting operating profitability. The labor-intensive nature of nursing, care, and staffing businesses exposes the company to wage inflation risks that may not be fully recoverable through price increases.
Segment profitability disparity: The Care segment operates at only 4.4% operating margin compared to Nursing at 19.3%, creating earnings vulnerability if the lower-margin Care business grows disproportionately or if Nursing segment faces headwinds. The substantial margin gap suggests structural profitability challenges in Care operations that could constrain overall group profitability if not addressed.
Regulatory and reimbursement risk: Given the company's concentration in healthcare-adjacent services (nursing and care), changes in government healthcare reimbursement policies, staffing regulations, or licensing requirements could materially impact revenue and profitability. The nursing and care sectors are subject to government oversight and funding structures that may change with fiscal policy adjustments or demographic pressures on public healthcare budgets.
[Industry Position] (Reference - Proprietary Analysis)
The company demonstrates distinctive positioning within the IT and Telecom industry classification, though its actual business mix in nursing, care, and staffing services suggests cross-industry characteristics.
Profitability: ROE 22.8% substantially exceeds the industry median of 8.3% (2025-Q3), placing the company in the top quartile for equity returns. Operating margin 7.2% falls slightly below the industry median of 8.2%, while net profit margin 5.2% approaches the median of 6.0%. The elevated ROE relative to operating margin suggests high asset turnover and financial leverage efficiency rather than superior operating margins.
Financial Health: Equity ratio 38.7% is materially below the industry median of 59.2%, indicating more aggressive financial leverage than typical industry peers. Current ratio 153.9% falls below the industry median of 215%, though still represents adequate liquidity. The company maintains conservative absolute leverage with debt-to-equity of 0.50x, but the lower equity ratio reflects a more leveraged capital structure relative to the primarily asset-light IT/telecom peer group.
Efficiency: Asset turnover 1.698 dramatically exceeds the industry median of 0.67, ranking among the highest in the comparison group. This exceptional capital efficiency drives the superior ROE despite middle-tier operating margins. Financial leverage of 2.59x exceeds the industry median of 1.66x, contributing to ROE amplification. The combination of high turnover and moderate leverage produces distinctive return characteristics.
Growth: Revenue growth of 15.7% YoY exceeds the industry median of 10.4%, placing the company in the upper tier of growth performers. EPS growth of 27.2% substantially outpaces the industry median of 22%, reflecting both revenue growth and margin expansion. The company's Rule of 40 score (revenue growth plus operating margin) of approximately 23% aligns with the industry median of 20%, indicating balanced growth-profitability trade-offs.
The company's asset turnover and ROE significantly outperform industry benchmarks, offset by below-median operating margins and equity ratios. This profile suggests a capital-efficient, higher-velocity business model with measured financial leverage, distinct from the typical asset-light, high-margin software/telecom archetype in the comparison group.
(Industry: IT and Telecom, N=104 companies, Comparison: 2025-Q3 period, Source: Proprietary analysis)
Strong profit leverage and improving capital efficiency characterize the earnings trajectory. Operating income growth of 33.0% significantly outpacing revenue growth of 15.7% demonstrates positive operating leverage, with operating margin expanding as the business scales. This margin progression, combined with asset turnover of 1.698 that dramatically exceeds industry norms, produces ROE of 22.8% in the top quartile of peer comparisons. The accelerating profit growth trend suggests the company has reached operational scale where incremental revenue drops more efficiently to the bottom line.
Progressive balance sheet strengthening accompanies earnings growth. Long-term borrowings decreased 29.0% from 9.0B yen to 6.4B yen while retained earnings increased 36.0% from 10.6B yen to 14.5B yen, reflecting active deleveraging funded by profit accumulation. Cash reserves of 19.6B yen provide 5.33x coverage of short-term liabilities, substantially exceeding typical corporate liquidity buffers. The combination of declining debt, growing equity, and ample cash indicates financial resilience and positions the company to weather operational volatility or pursue strategic investments without capital constraints.
Segment momentum shows broad-based strength with differentiated margin profiles. The Temporary Staffing segment achieved 50.8% operating profit growth on 20.2% revenue growth, demonstrating exceptional operational gearing. The core Nursing segment maintains premium 19.3% margins while growing steadily, providing stable earnings foundation. However, the Care segment's compressed 4.4% margin warrants monitoring for potential structural profitability challenges. The diversified segment portfolio provides some earnings stability, though approximately 55% of revenue concentration in Nursing creates dependency on that segment's continued health. Full-year guidance progress rates exceeding 95% for profits against only 75% for revenue at the Q3 stage indicates stronger-than-planned margin performance and high likelihood of guidance achievement or upside.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.